05/14/2024 3:06 PM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 3:13 PM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024 6:47 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 6:52 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 3:56 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 6:55 AM | Karyopharm Therapeutics (Filer)
| Form ARS | |
04/19/2024 6:36 AM | Karyopharm Therapeutics (Filer)
| Form DEF 14A | |
|
04/19/2024 6:44 AM | Karyopharm Therapeutics (Filer)
| Form DEFA14A | |
04/08/2024 4:08 PM | Karyopharm Therapeutics (Subject)
| Form SC TO-C | |
04/08/2024 3:40 PM | Karyopharm Therapeutics (Filer)
| Form PRE 14A | |
04/05/2024 4:20 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:36 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:37 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:38 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:39 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:40 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:41 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:34 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:36 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:43 AM | Karyopharm Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 6:35 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 9:33 AM | Avidity Partners Management LP (Filed by) Karyopharm Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024 5:06 AM | Karyopharm Therapeutics (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
02/08/2024 3:36 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:40 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:43 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:47 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:53 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:14 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:16 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 12:50 PM | Karyopharm Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/08/2024 8:00 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 7:40 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 4:03 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Tiny AI projects with huge promise hiding in plain sight … (Ad) I’ve developed a system that’s helped me find huge winners in the past.
Now my system has alerted me to the next four altcoins that could be the next superstars. Click here to find out who they are. |
11/07/2023 4:32 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 6:57 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 6:37 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/05/2023 3:46 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 3:07 PM | BOHLIN GAREN G (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:27 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:29 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 7:06 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/01/2023 7:17 AM | Karyopharm Therapeutics (Issuer) Su Zhen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/01/2023 7:20 AM | Karyopharm Therapeutics (Issuer) Su Zhen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/02/2023 7:59 AM | Karyopharm Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/02/2023 6:48 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023 6:37 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2023 4:37 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2023 1:26 PM | Karyopharm Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
07/06/2023 4:36 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |